Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-The-Counter Human Use; Final Rule for Professional Labeling of Aspirin, Buffered Aspirin, and Aspirin in Combination With Antacid Drug Products; Correction

요약

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of October 23, 1998 (63 FR 56802). The document provided for professional labeling for over-the- counter (OTC) internal analgesic, antipyretic, and antirheumatic drug products containing aspirin, buffered aspirin, and aspirin in combination with an antacid. The document published with some inadvertent editorial errors. This document corrects those errors.